GRAIL LLC is a biotechnology company based in California that develops tests for detecting multiple cancers early. Its lobbying focuses on Medicare and broader health policy as they relate to oncology and early multi-cancer detection, including diagnostics and screening, and it has referenced H.R.842 (the Nancy Gardner Sewell Multi-Cancer Early Detection Screening Act). It has filed reports showing $240,000 in lobbying and hired Miller Strategies, LLC.
Show the dominant industry call, how mixed the client looks, and the allocation across the top labeled sectors.
Annual totals based on disclosed filing amounts.
Issue rankings are based on disclosed activity mentions, with filing amounts apportioned evenly across issues within the same filing.
The lobbying registrants handling this client, ranked by disclosed filing amounts.
Lobbyists are ranked by appearances and an equal share of each filing's reported amount.
ASHLEY GUNN
The latest disclosures for this client.
MILLER STRATEGIES, LLC
Q1MILLER STRATEGIES, LLC
Q4The entities named in disclosed activities are the clearest available signal for where the client is aiming attention.
MILLER STRATEGIES, LLC
JEFFREY MILLER
MILLER STRATEGIES, LLC
JONATHAN HILER
MILLER STRATEGIES, LLC
ms JESSICA ANNE MANDEL
MILLER STRATEGIES, LLC
STEPHEN RUPPEL
MILLER STRATEGIES, LLC
NATALIE MCINTYRE
MILLER STRATEGIES, LLC
MILLER STRATEGIES, LLC
Q3MILLER STRATEGIES, LLC
Q2MILLER STRATEGIES, LLC
Q1